Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Leukemia, Myeloid, Acute 6Neoplasm Metastasis 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Lung Neoplasms 3Endometrial Neoplasms 3Congenital Abnormalities 3Colonic Neoplasms 3Breast Neoplasms 3Sarcoma 2Oropharyngeal Neoplasms 2Neuroblastoma 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Anus Neoplasms 2Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Rituximab 28Cyclophosphamide 14ibrutinib 10Vincristine 10Prednisone 10Doxorubicin 10Bendamustine Hydrochloride 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6zanubrutinib 5acalabrutinib 4Lenalidomide 4Cyclosporine 4orelabrutinib 3Whole-Body Irradiation 3R-CHOP protocol 3Mycophenolic Acid 3Melphalan 3Interferon-alpha 3Etoposide 3Dexamethasone 3Cytarabine 3Cyclosporins 3venetoclax 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2VAP-cyclo protocol 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Mantle-Cell × Observation × Clear all
NCT00877214 2024-08-22

MAINTAIN

University of Giessen

Phase 3 Active not recruiting
1,272 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT00921414 2018-04-27

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

French Innovative Leukemia Organisation

Phase 3 Completed
299 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡